Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1623 1626
This examiner grants 78% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18545711 | PROCESS FOR THE PREPARATION OF NLRP3 INHIBITORS | Non-Final OA | Hoffmann-La Roche Inc. |
| 18406841 | Method for Treating Diseases Using SMARCA2/4 Degraders | Non-Final OA | Aurigene Oncology Limited |
| 17751474 | PROTECTED TRIAZABUTADIENE COMPOSITIONS FOR CELLULAR STUDIES IN INTACT BIOLOGICAL SYSTEMS | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 18470548 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | Non-Final OA | AstraZeneca AB |
| 18797055 | PROCESS FOR THE PREPARATION OF MIRABEGRON FREE FROM GENOTOXIC IMPURITIES | Final Rejection | ZYDUS LIFESCIENCES LIMITED |
| 17821952 | SELECTIVE ANDROGEN RECEPTOR COVALENT ANTAGONISTS (SARCAs) AND METHODS OF USE THEREOF | Non-Final OA | University of Tennessee Research Foundation |
| 17636511 | PHARMACEUTICAL FORMULATIONS OF TENOFOVIR ALAFENAMIDE | Non-Final OA | Gilead Sciences, Inc. |
| 17921260 | A FUNGICIDAL COMPOUND AND PROCESS OF PREPARATION THEREOF | Non-Final OA | UPL Limited |
| 18466489 | PROCESS FOR PREPARATION OF IPCONAZOLE & ITS INTERMEDIATES | Non-Final OA | UPL Europe LTD |
| 18577481 | MODULATORS OF PROTEIN KINASES | Non-Final OA | VIBLIOME THERAPEUTICS, LLC |
| 18239315 | Composition for preventing or treating cachexia and muscle loss | Non-Final OA | METAFINES.CO.LTD. |
| 18276709 | PHARMACEUTICALLY ACCEPTABLE SALTS OF PSILOCIN AND USES THEREOF | Non-Final OA | Eleusis Therapeutics US, Inc. |
| 18276588 | ANTIBACTERIAL COMPOUNDS | Non-Final OA | Blacksmith Medicines, Inc. |
| 18258666 | METHOD FOR CATALYTICALLY ACTIVATING CARBON DIOXIDE AS CARBONYLATION REAGENT WITH INORGANIC SULFUR | Non-Final OA | Inner Mongolia University of Technology |
| 18036269 | NOVEL CYCLIC COMPOUNDS, METHOD FOR THEIR PREPARATION AND THE USE OF SAID CYCLIC COMPOUNDS IN COSMETIC PREPARATIONS | Non-Final OA | EBERHARD KARLS UNIVERSITAET TUEBINGEN |
| 17651439 | OXADIAZOLES FOR USE IN CONTROLLING PHYTOPATHOGENIC FUNGI | Non-Final OA | PI INDUSTRIES LTD. |
| 18015561 | DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE | Final Rejection | BEIGENE, LTD. |
| 18012985 | COMPOSITION OF COMPOUNDS THAT MODULATE CELL METABOLISM AND METHODS OF USE | Final Rejection | CRESCENTA BIOSCIENCES |
| 18011408 | AMIDO COMPOUNDS | Non-Final OA | Anaxis Pharma Pty Ltd |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy